VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PBYI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HomeStocksPBYIInstitutional Holders

PBYI logoPuma Biotechnology, Inc. (PBYI) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership increased this quarter (+1.25 pp), though top 10 holders maintain a highly concentrated 58.8% of institutional value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
76.2%$286M total value · ▲ +1.25 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
68 / 100Bullish
Institutions & Flow162 holders+6 net flow (+20 / -14)

AI Insights & Key Takeaways

  • Positive Institutional Flow (+6)
  • Renaissance Technologies Llc and Millennium Management Llc maintain significant positions
  • Top 10 holders control 58.8% of institutional value
  • No Insider Signal

Top Institutional Holders of PBYI

Ranked by reported Q2 2026 13F market value

Top 10 Holders
58.8%
Top 25 Holders
83.4%

Share of total reported institutional value in PBYI held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1ACORN CAPITAL ADVISORS, LLC4.1M$33.5M0.0%8.117%9.14%
2BlackRock, Inc.3.8M$30.9M+5.7%7.475%0.00%
3AMERICAN CENTURY COMPANIES INC2.3M$18.8M+21.1%4.558%0.01%

Quarterly Institutional Activity

Filings activity in PBYI during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers20Added To122Trimmed17Exited14
  • ACORN CAPITAL ADVISORS, LLC$33.5M
  • BlackRock, Inc.$30.9M
  • AMERICAN CENTURY COMPANIES INC

PBYI Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 2026162+3.2%76.18%+1.25 pp$286M+29%
Q1 2026157+2.6%74.93%+4.32 pp$222M+13%
Q4 2025153+14%70.61%+1.54 pp$196M+15%
Q3 2025134+11%69.07%+4.09 pp$170M+67%
Q2 2025121+3.4%64.98%+3.42 pp$102M+22%
Q1 2025117+7.3%

How PBYI Compares to Peers

Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
DMRADamora Therapeutics, Inc.$1.46B200.0%99+33
FTHFaeth Therapeutics, Inc.$568M54.5%45+16
LONALeonaBio, Inc.$17M184.4%45+4
KYNBKyntra Bio, Inc.$15M26.9%29-4
CNSYCerenome, Inc.$5M4.8%24-5

PBYI — Frequently Asked Questions

Quick answers to the most common questions about buying PBYI stock.

What percentage of PBYI is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Puma Biotechnology, Inc. stands at 76.2%, held across 162 reporting institutions.

Who is the largest institutional holder of PBYI?

ACORN CAPITAL ADVISORS, LLC is the largest reported institutional holder of PBYI, with approximately 4,131,299 shares worth $0.03B as of Q2 2026.

Is PBYI a hedge fund favorite?

Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of PBYI, including RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC.

What is PBYI's Smart Money Score?

Our composite Smart Money Score for PBYI is 68 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought PBYI this quarter?
4RENAISSANCE TECHNOLOGIES LLC1.8M$14.9M-5.5%3.608%0.02%
5VANGUARD CAPITAL MANAGEMENT LLC1.8M$14.9M+1.0%3.606%0.00%
6VANGUARD PORTFOLIO MANAGEMENT LLC1.8M$14.8M+5.2%3.587%0.00%
7DIMENSIONAL FUND ADVISORS LP1.5M$12.3M+5.7%2.982%0.00%
8GEODE CAPITAL MANAGEMENT, LLC1.3M$10.9M+31.7%2.631%0.00%
9O'SHAUGHNESSY ASSET MANAGEMENT, LLC1.1M$9.1M-1.3%2.208%0.04%
10STATE STREET CORP952K$7.7M+3.8%1.871%0.00%
11KENNEDY CAPITAL MANAGEMENT LLC873K$7.1M-1.8%1.716%0.13%
12BRIDGEWAY CAPITAL MANAGEMENT, LLC792K$6.4M+2.1%1.555%0.11%
13RITHOLTZ WEALTH MANAGEMENT750K$6.1M-3.2%1.473%0.05%
14AQR CAPITAL MANAGEMENT LLC725K$5.9M-9.4%1.425%0.00%
15GOLDMAN SACHS GROUP INC669K$5.4M-0.1%1.315%0.00%
16NORTHERN TRUST CORP652K$5.3M+1.7%1.282%0.00%
17Connor, Clark & Lunn Investment Management Ltd.643K$5.2M-17.9%1.263%0.01%
18UBS Group AG637K$5.2M+19.2%1.251%0.00%
19MILLENNIUM MANAGEMENT LLC602K$4.9M-59.2%1.183%0.00%
20ARROWSTREET CAPITAL, LIMITED PARTNERSHIP532K$4.3M-1.1%1.046%0.00%
21SEI INVESTMENTS CO419K$3.4M-17.6%0.823%0.00%
22GLOBEFLEX CAPITAL L P383K$3.1M+9.5%0.752%0.40%
23Bank of New York Mellon Corp361K$2.9M+3.7%0.709%0.00%
24D. E. Shaw & Co., Inc.316K$2.6M-9.9%0.622%0.00%
25STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM309K$2.5M+13.3%0.607%0.00%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in PBYI — a direct measure of their conviction.

$18.8M
  • RENAISSANCE TECHNOLOGIES LLC$14.9M
  • VANGUARD CAPITAL MANAGEMENT LLC$14.9M
  • VANGUARD PORTFOLIO MANAGEMENT LLC$14.8M
  • DIMENSIONAL FUND ADVISORS LP$12.3M
  • GEODE CAPITAL MANAGEMENT, LLC$10.9M
  • O'SHAUGHNESSY ASSET MANAGEMENT, LLC$9.1M
  • STATE STREET CORP$7.7M
  • KENNEDY CAPITAL MANAGEMENT LLC$7.1M
  • BRIDGEWAY CAPITAL MANAGEMENT, LLC$6.4M
  • 61.56%
    +5.23 pp
    $83M
    +2.0%
    Q4 2024109+7.9%56.33%143.66 pp$82M75%
    Q3 2024101—199.99%—$331M—

    Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

    20 institutions opened new positions in PBYI during Q2 2026, while 14 fully exited. 122 added to existing positions and 17 trimmed.

    How is institutional ownership of PBYI changing?

    PBYI institutional ownership rose by 1.25 percentage points quarter-over-quarter, with a net change of +5 holders.

    How concentrated is PBYI ownership among the top holders?

    The top 10 institutions account for 58.8% of all reported 13F value in PBYI, and the top 25 account for 83.4%.

    How does PBYI compare to Oncology Biotech on institutional ownership?

    Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.

    Where does this PBYI institutional ownership data come from?

    All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

    PBYIPuma Biotechnology, Inc.
    $7.22$367M
    Overview & Tools
    OverviewChart Terminal ↗Visualize
    Valuation & Forecasts
    Valuation ModelsEstimatesDCF Model
    Price & Analyst Data
    Analyst TargetsPrice History
    Financial Statements
    Income StatementBalance SheetCash FlowRatios & Margins
    Performance
    P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
    Discovery & Screens
    Live BreakoutsStock ScreenerOwnership